Target mRNA abundance dilutes microRNA and siRNA activity Aaron Arvey ISMB 2010 MicroRNA Mike needs help to degrade all the mRNA transcripts!

Slides:



Advertisements
Similar presentations
Rhiana Lau MMG C174 Professor Simpson
Advertisements

3B1 Gene regulation results in differential GENE EXPRESSION, LEADING TO CELL SPECIALIZATION.
RNA Interference (RNAi) Pathway
Improving miRNA Target Genes Prediction Rikky Wenang Purbojati.
Naveen K. Bansal and Prachi Pradeep Dept. of Math., Stat., and Comp. Sci. Marquette University Milwaukee, WI (USA)
Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs LEE P. LIM, NELSON C. LAU, PHILIP GARRETT-ENGELE ANDREW GRIMSON,
Computational biology seminar
Presenting: Asher Malka Supervisor: Prof. Hermona Soreq.
 MicroRNAs (miRNAs) are a class of small RNA molecules, about ~21 nucleotide (nt) long.  MicroRNA are small non coding RNAs (ncRNAs) that regulate.
Chapter 15 Noncoding RNAs. You Must Know The role of noncoding RNAs in control of cellular functions.
Mammalian RNAi pathways Michael T. McManus MIT Center for Cancer Research.
Molecular Cellular Biology-I (MCB-I) PCB 6025 M. Alejandro Barbieri M. Alejandro Barbieri Office: HLS 318C/214 Hours: by appointment.
Control of Gene Expression Eukaryotes. Eukaryotic Gene Expression Some genes are expressed in all cells all the time. These so-called housekeeping genes.
MicroRNA Targets Prediction and Analysis. Small RNAs play important roles The Nobel Prize in Physiology or Medicine for 2006 Andrew Z. Fire and Craig.
Transfection. What is transfection? Broadly defined, transfection is the process of artificially introducing nucleic acids (DNA or RNA) into cells, utilizing.
Introduction Hepatitis C Virus
Eukaryotic Gene Regulation
Regulating Gene Expression from RNA to Protein. Fig 16.1 Gene Expression is controlled at all of these steps: DNA packaging Transcription RNA processing.
Finish up array applications Move on to proteomics Protein microarrays.
RNA Folding. RNA Folding Algorithms Intuitively: given a sequence, find the structure with the maximal number of base pairs For nested structures, four.
RNA interference Definition: RNA interference (RNAi) is a mechanism where the presence of certain fragments.
MBP1007/ Nucleic Acids A functional mRNA: The cytoplasmic story Objectives (1) To discuss the iNUTS and iBOLTS of how mRNAs function in the cytoplasm.
SiRNA and Epigenetic Asma Siddique Saloom Aslam Syeda Zainab Ali.
Changes to Syllabus: Quizzes put back: Change Oct. 3 to Oct. 17
What is RNA interference?
Welcome Everyone. Self introduction Sun, Luguo ( 孙陆果) Contact me by Professor in School of Life Sciences & National Engineering.
Marco Magistri , Journal Club. A non-coding RNA (ncRNA) is any RNA molecule that is not translated into a protein “Structural genes encode proteins.
SmallRNAs Small molecules, big functions. Brief history The first described microRNA, lin-4 was cloned and characterised as a translational repressor.
Conditional systems - principles Conditional systems may function on the basis of: - regulatory proteins - aptamers - allosteric ribozymes - antisense.
Predicting protein degradation rates Karen Page. The central dogma DNA RNA protein Transcription Translation The expression of genetic information stored.
Biochemistry 412 RNA Interference (RNAi) (see also siRNA, micRNA, stRNA, etc.) 8 April 2005 Lecture.
Nature, 2008, Doi: /nature07103 Semrah Kati
Regulation and Gene Expression
The Power of “Genetics” LOSS OF FUNCTION Easy in yeast Difficult in mammals Powerful tool to address roles in developmental or signaling networks Gene.
Transcriptomics Sequencing. over view The transcriptome is the set of all RNA molecules, including mRNA, rRNA, tRNA, and other non coding RNA produced.
Target mRNA abundance dilutes microRNA and siRNA activity Aaron Arvey Memorial Sloan Kettering Cancer Center MicroRNAs and Human Disease February 12th.
AP Biology Control of Prokaryotic (Bacterial) Genes.
Project: Cellular microRNA profilings during the infections of the hepatitis C virus and the influenza A virus Yu Li Postdoc Fellow Katze Lab.
RNA-ligand interactions and control of gene expression
PLANT BIOTECHNOLOGY & GENETIC ENGINEERING (3 CREDIT HOURS) LECTURE 13 ANALYSIS OF THE TRANSCRIPTOME.
Vectors for RNAi.
Fig. 1. GLP-1 induces miR-132 and miR-212 expression in pancreatic β-cells in vitro and in vivo. (A) MiRNA expression profiling of GLP-1 treated INS-1.
Expression profile of oncomiRs and tumor-suppressor miRs in urothelial carcinoma of the bladder Apostolos Zaravinos 1, George I. Lambrou 2, Jelena Radojicic.
Homework #2 is due 10/17 Bonus #1 is due 10/24 Office hours: M 10/ :30am 2-5pm in Bio 6.
CAMPBELL BIOLOGY IN FOCUS © 2014 Pearson Education, Inc. Urry Cain Wasserman Minorsky Jackson Reece Lecture Presentations by Kathleen Fitzpatrick and Nicole.
Mestrado Integrado em Medicina Biologia Celular e Molecular II
Interfering RNA (干擾RNA)
Date of download: 7/10/2016 Copyright © 2016 McGraw-Hill Education. All rights reserved. Basic steps of gene expression—transcription factors regulate.
Chapter 18 – Gene Regulation Part 2
Conditional systems - principles
RNAi Overview
miRNA genomic organization, biogenesis and function
A ceRNA Hypothesis: The Rosetta Stone of a Hidden RNA Language?
Long Noncoding RNA in Prostate, Bladder, and Kidney Cancer
Regulation of Gene Expression
Supplementary figure S1 by Shin et al.
Loss of SMARCA4 expression or activity derepresses miR-27a.
Coordinately Controlled Genes in Eukaryotes
New Hope for a MicroRNA Therapy for Liver Cancer
MicroRNAs: regulators of gene expression and cell differentiation
Rafael Kramann, Marcus J. Moeller  Kidney International 
mRNA Degradation and Translation Control
Noncoding RNA roles in Gene Expression
Volume 48, Issue 5, Pages (December 2012)
siRNA / microRNA epigenetics stem cells
Tanya Vavouri, Jennifer I. Semple, Rosa Garcia-Verdugo, Ben Lehner 
Rational Design of Therapeutic siRNAs: Minimizing Off-targeting Potential to Improve the Safety of RNAi Therapy for Huntington's Disease  Ryan L Boudreau,
The Power of “Genetics”
Presentation transcript:

Target mRNA abundance dilutes microRNA and siRNA activity Aaron Arvey ISMB 2010 MicroRNA Mike needs help to degrade all the mRNA transcripts!

Target mRNA abundance dilutes microRNA and siRNA activity Erik Larsson Chris Sander Christina Leslie Debbie Marks

Background: Small RNAs mediate mRNA degradation Small RNAs are 19-25nt RNA Induced Silencing Complex (RISC) –Protein complex that uses small RNA to guide degradation microRNAs –Processed from non-coding genes siRNAs (for our purposes) –Transfected into the cell –Knockdown specific gene –Unintended “off-targets” are also downregulated microRNA pathway siRNA pathway

Background: Transfected small RNAs induce target mRNA degradation Double stranded RNA molecules are transfected into cell lines Concentrations of small RNA are very high, ~100nM Target mRNAs are degraded microRNAs and siRNAs

Background: Target Prediction microRNAs –Transcript 3’ UTR is most likely to be targeted –microRNA 5’ “seed” region guides targeting siRNAs –Off-targets have similar targeting rules as microRNAs –Primary targets have nearly exact complementarity microRNA targets and siRNA off-targets siRNA primary targets

microRNAs induce different amounts of downregulation Big Shift Little Shift

Concept: Small RNAs with many targets downregulate each individual target to a lesser extent

Meta-analysis of high throughput studies to explore hypothesis 178 transfection experiments in HeLa and HCT116 cell lines –61 miRNA-mimics (Lim 2005, Grimson 2007, He 2007, Linsley 2007, Selbach 2008) –98 siRNA (Kittler 2007, Anderson 2008, Jackson 2006, Schwarz 2006) –19 chimeras (Lim et al, 2005, Anderson 2008) Microarray assay pre- and post-transfection RNA-Seq quantifies mRNA target abundance (Morin 2008)

Downregulation is significantly correlated with target concentration

Downregulation of siRNA primary target and off-targets is significantly correlated with off-target concentration

Shared targets show that downregulation is determined by target abundance Measure target abundance on all targets Measure downregulation on shared targets

Pairwise examples Examples of differential regulation on shared targets

Pairwise examples Smad5 downregulation –miR-155: –miR-106: -0.1 Target abundance –miR-155: 142 –miR-106: 315 Differences –Downregulation: 1.19 –Abundance: 173

Shared targets are more downregulated by microRNAs with fewer targets

Conclusion: Small RNAs with more targets downregulate each target to a lesser extent.

Consequences: Endogenous regulation by microRNAs Each microRNA is quantitatively unique –Definition of target should perhaps be different for different microRNAs, targets are likely to be quantitatively different The cell as a very finely tuned system of regulation –Increase in one target mRNA detracts from downregulation of another target mRNA –microRNA regulation is always using all available degradation machinery (Khan et al2009), but is still stretched thin Evolutionary constraints –Possibility 1: anti-targets (mRNA transcripts that ‘avoid’ being co-expressed with microRNA) enable the cell to avoid high target concentration –Possibility 2: microRNA expression increases when target mRNAs increase, dosage compensation

Consequences: Target abundance limits siRNA activity Limits knockdown of primary target –May limit drug efficacy, especially in small concentration –May limit functional genomic screens Limits the knockdown of off-targets –Increase in off-targets may actually decrease toxicity (Anderson et al, 2008)

Functional Examples Cancer: PTEN pseudogene 1 (PTENP1) regulates cell cycle by way of PTEN (Poliseno et al) Environmental Response: Non-coding RNA regulates phosphate starvation response (Franco Zorrilla et al)

Kinetics Were we guaranteed to find this result? –No: Depends on dynamic range of kinetic relationship Degradation is a function of speed, time, and concentration –So far, we have only considered downregulation with respect to concentration Downregulation has been defined as the ratio: Can also consider the total number of molecules degraded v

Background: RISC Kinetics Multi-turnover enzyme –Single loaded RISC is able to degrade many mRNA transcripts (Hutvágner & Zamore, 2002) RISC is saturated with small RNA upon transfection (Khan et al, 2009) Degradation in lysate is very fast (Haley & Zamore, 2004) [RISC] + [target]  [RISC+target]  [RISC] + [product]

Haley & Zamore (2004) Kinetics in drosophila lysate Product (nM) Background: RISC Kinetics Degradation kinetics depend on target concentration 1nM RISC in lysate –Slope of line is velocity –Transcripts degraded at rate of nM transcript/day Target concentration in cell is likely to be in the range 1-60nM 72nM > 60nM –Ignores transcriptional rate –Ignores cellular context –Ignores localization Target Concentration (nM) Change in molecules (velocity nM/min) 1nM 5nM 20nM 60nM

Velocity is correlated with target abundance and follows Michaelis-Menten kinetics Velocity can be estimated by

Velocity is correlated with target abundance and follows Michaelis-Menten kinetics Concentration of Predicted Targets (RPN) Velocity (a.u.)

Questions Erik Larsson Chris Sander Christina Leslie Debbie Marks

We control for several alternative explanations A+U content – Not correlated 3’ UTR length –Correlated, controllable by shared targets Expression of individual targets –Correlated, controllable by shared targets

Individual target abundance is correlated with downregulation

Caveats of shared-target analysis False positive rate may increase sub-linearly –If false positive rate increases with number of predicted targets, becomes harder to control –The siRNA analysis completely controls for this (since there is only a single primary target!) Length of UTR is 2x normal length in shared targets –Normal: 1167nt – Shared target: 2041nt –Longer 3’ UTR may lead to increased downregulation, though this would not give preference for a specific microRNA

Methods: Target Prediction

Methods: Target Abundance

Methods: Downregulation

Time Course

Past Evidence - In Vivo Franco-Zorrilla et al (2007)

Correlation between siRNA off-target abundance and primary target downregulation Off Target Abundance Log2 Expression Ratio of primary target

Past Evidence: Dilution In Solution Haley & Zamore (2004)

Past Evidence - Toxicity Anderson et al (2008)

Past Evidence - Dilution In Cells Ebert et al 2007

Normalization